Anavex Life Sciences Corp (AVXL)

[Steady_T]

What label is applied to the trial is not really important.

What is important is that a trial is approved.

It is very short term. It requires a quite small number of subjects. It leads directly to the larger placebo controlled trial.

Looks like a large portion of the trial costs will be borne by the Rett Foundation. That is good for two reasons. One because it lessens the impact on company resources. Two because it demonstrates the Rett foundation's opinion of 2-73 is high enough for them to put money behind getting it developed.